Home/Filings/4/0001127602-19-003330
4//SEC Filing

Schomburger Jeffrey K 4

Accession 0001127602-19-003330

CIK 0000080424other

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 1:03 PM ET

Size

11.5 KB

Accession

0001127602-19-003330

Insider Transaction Report

Form 4
Period: 2019-01-31
Schomburger Jeffrey K
Global Sales Officer, CBD
Transactions
  • Award

    Restricted Stock Units

    2018-11-15+109.6231,456.854 total
    Common Stock (109.623 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2019-01-3141,0880 total
    Exercise: $63.28From: 2013-02-26Exp: 2020-02-26Common Stock (41,088 underlying)
  • Exercise/Conversion

    Common Stock

    2019-01-31$63.28/sh+41,088$2,600,04971,762.522 total
  • Sale

    Common Stock

    2019-01-31$95.00/sh41,088$3,903,36030,674.522 total
Holdings
  • Common Stock

    (indirect: By Trust)
    9,831.298
Footnotes (4)
  • [F1]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
  • [F2]Reflects adjustment to PST through December 31, 2018.
  • [F3]Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
  • [F4]These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

Issuer

PROCTER & GAMBLE Co

CIK 0000080424

Entity typeother

Related Parties

1
  • filerCIK 0001630117

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 1:03 PM ET
Size
11.5 KB